Amphion Innovations (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK.
Amphion has significant shareholding in 8 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million.
Amphion also has two specialized entities, MSA Holding, a joint venture intended to replicate the Amphion model in the Gulf, and DataTern, Inc., established to exploit IP opportunities within the Company's Partner Companies.
For more information, visit
http://www.amphionplc.com 
